Search hospitals > Indiana > Elkhart

Elkhart General Hospital

Claim this profile
Elkhart, Indiana 46514
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Ovarian Cancer
Conducts research for Solid Tumors
Conducts research for Prostate Cancer
241 reported clinical trials
1 medical researcher
Photo of Elkhart General Hospital in ElkhartPhoto of Elkhart General Hospital in Elkhart

Summary

Elkhart General Hospital is a medical facility located in Elkhart, Indiana. This center is recognized for care of Breast Cancer, Lung Cancer, Ovarian Cancer, Solid Tumors, Prostate Cancer and other specialties. Elkhart General Hospital is involved with conducting 241 clinical trials across 280 conditions. There are 1 research doctors associated with this hospital, such as Troy Weirick, MD.

Area of expertise

1Breast Cancer
Global Leader
Elkhart General Hospital has run 58 trials for Breast Cancer. Some of their research focus areas include:
ER positive
PR positive
Stage II
2Lung Cancer
Global Leader
Elkhart General Hospital has run 27 trials for Lung Cancer. Some of their research focus areas include:
Stage I
Stage II
Stage III

Top PIs

Troy Weirick, MDElkhart General Hospital4 years of reported clinical research
Studies Coronary Artery Disease
Studies Coronary Artery Stenosis
2 reported clinical trials
3 drugs studied

Clinical Trials running at Elkhart General Hospital

Oropharyngeal Carcinoma
Oral Squamous Cell Carcinoma
Throat Cancer
Laryngeal Squamous Cell Carcinoma
Squamous Cell Carcinoma
Image of trial facility.

Chemotherapy + Radiation Therapy

for Head and Neck Cancer

This phase II/III trial studies how well radiation therapy works when given together with cisplatin, docetaxel, cetuximab, and/or atezolizumab after surgery in treating patients with high-risk stage III-IV head and neck cancer the begins in the thin, flat cells (squamous cell). Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Drugs used in chemotherapy, such as cisplatin and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to compare the usual treatment (radiation therapy with cisplatin chemotherapy) to using radiation therapy with docetaxel and cetuximab chemotherapy, and using the usual treatment plus an immunotherapy drug, atezolizumab.
Recruiting1 award Phase 2 & 321 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Elkhart General Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security